Tokio Marine Asset Management CO LTD Bristol Myers Squibb CO Transaction History

Tokio Marine Asset Management CO LTD

$1.96 Billion
Q1 2024

A detailed history of Tokio Marine Asset Management CO LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 47,197 shares of BMY stock, worth $1.96 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

47,197

Previous 44,965 4.96%

Holding current value

$1.96 Million

Previous $2.31 Million 10.92%

% of portfolio

0.13%

Previous 0.13%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $107,091 - $121,420	2,232 Added 4.96%	47,197 $2.56 Million
Q4 2023 Feb 02, 2024	SELL	$48.48 - $57.85 $137,489 - $164,062	-2,836 Reduced 5.93%	44,965 $2.31 Million
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $226,581 - $253,353	-3,914 Reduced 7.57%	47,801 $2.77 Million
Q2 2023 Jul 28, 2023	BUY	$63.71 - $70.74 $82,249 - $91,325	1,291 Added 2.56%	51,715 $3.31 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $305,091 - $346,042	4,643 Added 10.14%	50,424 $3.49 Million

Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $520,448 - $616,284	7,600 Added 19.91%	45,781 $0
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $623 - $368,601	4,797 Added 14.37%	38,181 $2.71 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $345,380 - $380,384	4,756 Added 16.61%	33,384 $2.57 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $125,111 - $150,020	2,035 Added 7.65%	28,628 $2.09 Million
Q4 2021 Jan 26, 2022	BUY	$53.63 - $62.52 $67,520 - $78,712	1,259 Added 4.97%	26,593 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $119,405 - $139,867	2,018 Added 8.66%	25,334 $1.5 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $8,605 - $9,371	139 Added 0.6%	23,316 $1.56 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $59,043 - $66,406	-995 Reduced 4.12%	23,177 $1.46 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $147,583 - $167,239	2,556 Added 11.82%	24,172 $1.5 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $81,378 - $90,177	1,417 Added 7.02%	21,616 $1.3 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $66,825 - $78,125	1,219 Added 6.42%	20,199 $1.19 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $106,488 - $154,751	2,295 Added 13.75%	18,980 $1.06 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $141,577 - $184,674	2,877 Added 20.84%	16,685 $1.07 Million
Q3 2019 Oct 29, 2019	BUY	$42.77 - $50.71 $261,367 - $309,888	6,111 Added 79.39%	13,808 $700,000
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $21,685 - $23,979	486 Added 6.74%	7,697 $349,000
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $26,891 - $32,064	596 Added 9.01%	7,211 $344,000
Q4 2018 Feb 04, 2019	BUY	$48.76 - $63.23 $24,087 - $31,235	494 Added 8.07%	6,615 $344,000
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $2.52 Million - $2.84 Million	-45,686 Reduced 88.18%	6,121 $380,000
Q2 2018 Jul 18, 2018	SELL	$50.53 - $62.98 $1.01 Million - $1.26 Million	-20,049 Reduced 27.9%	51,807 $2.87 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $249,207 - $286,887	-4,159 Reduced 5.47%	71,856 $4.55 Million
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $228,131 - $248,722	-3,806 Reduced 4.77%	76,015 $4.66 Million
Q3 2017 Oct 30, 2017	SELL	$55.23 - $63.74 $400,693 - $462,433	-7,255 Reduced 8.33%	79,821 $5.09 Million
Q2 2017 Jan 11, 2018	SELL	N/A	-45,566 Reduced 34.35%	87,076 $4.85 Million
Q1 2017 Jan 11, 2018	SELL	N/A	-97,337 Reduced 42.32%	132,642 $7.21 Million
Q4 2016 Jan 11, 2018	SELL	N/A	-31,531 Reduced 12.06%	229,979 $13.4 Million
Q3 2016 Jan 11, 2018	SELL	N/A	-12,593 Reduced 4.59%	261,510 $14.1 Million
Q2 2016 Jan 11, 2018	SELL	N/A	-5,497 Reduced 1.97%	274,103 $20.2 Million
Q1 2016 Jan 11, 2018	BUY	N/A	279,600	279,600 $17.9 Million

Others Institutions Holding BMY

# of Institutions

2,554

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $88.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.

Account

Tokio Marine Asset Management CO LTD Bristol Myers Squibb CO Transaction History